Date: September, 2018
APRINOIA Therapeutics is a company dedicated to developing medicine for neurodegenerative diseases. At the 1st CTAD Asia-China Conference held in Shanghai on September 2, 2018, APRINOIA Therapeutics shared its development strategies and goals for the future. Instinctif Partners organized a media briefing that secured key medical and business media in China to interview and build rapport with top management of the company. There was a total of 30 pieces of media coverage which has offered the public a better understanding of APRINOIA Therapeutics’s R&D achievements and products for Alzheimer`s disease.